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Johannes-Gutenberg- Universitiit, Mainz, FR Germany
The analytical performance of the selective, automatic multiana-
lyser Olympus AU 5031 was evaluated over four months and
assessedforpracticabilityfor another eight months. The evaluation
followed the ECCLS guidelines. Twenty routine parameters were
measured. In addition, sodium and potassium were determined on
an attachedflame photometric unit. Both the agreement between the
eights photometers per unit and the temperature behaviour in the
cuvettes was satisfactory.. The imprecisions were very good. The
within-run imprecision was below 1.5% for the majority of the
parameters. The imprecision between days was below 5%, with the
exception of creatine phosphokinase (7"4%). Glutamate dehydro-
genase gave an imprecision of between 4"0% and 15"9%, which,
however, is more likely due to the low activities measured rather
than thefault ofanalyser. The recovery ofthe assigned values in 12
control sera was between 95% and 105% for 14 tests. Three ofthe
remaining eight tests yielded recoveries with deviations between
10% and 18% (alanine aminotransferase, aspartate aminotrans-
ferase and bilirubin). No drift effects were observed and neither a
sample carry-over nor a reagent carry-over were detected. Most tests
were linear over a very wide range. Only afew tests (mainly lipase
and glutamate dehydrogenase) required measurement repetitions
with diluted samples. The correlation with routine instruments and
tests was close. However, corrections were necessaryfor 14 ofthe 22
tests. This was not due to the performance of the analyser but,
rather, to the different methodologies ofcompared tests, or different
working temperatures on the comparison instruments, or a lack of
accuracyfor some of the AU tests.
Introduction
The Olympus AU is an analyser for medium and large
laboratories. This paper reports on the performance of
the AU 5031. The evaluation lasted six months and the
instrument has been in routine use for a further eight
months. Although the authors accept that only a
multicentre evaluation, as suggested by ECCLS guide-
lines [1], allows a truly representative assessment for an
analyser, multicentre evaluations of analysers of this size
require considerable time. The evaluation data are
reported here because there is a growing interest in the
performance characteristics of the Olympus 5000.
The protocol of this evaluation followed the ECCLS
guidelines; changes were made only if they seemed
appropriate to the specific features of the AU analyser.
"
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Recently, two evaluations of this analyser have been
published [1 and 2]. They, too, followed the ECCLS
guidelines but some aspects reported here were not
studied or were approached differently. Therefore, the
present data and that in the previous reports may serve as
a preliminary multicentre evaluation.
General description of the AU 5000 analyser
The AU 5000 Analyser is constructed according to a
modular concept. Any analyser consists of up to eight
units. Each unit is basically a complete analyser and is
equipped with either four, eight or 12 reagent lines. The
specifications of such a unit are given in table 1. By
combining several units the performance of the resulting
analyser can be tailored to the requirements of the user in
respect to sample throughput, number oftests or both. By
choosing the maximum number of 12 reagent lines, the
user gains a higher number ofavailable tests at the cost of
sample throughput. Possible combinations of available
test numbers and throughput capacities are displayed in
table 2. However, once a certain configuration is installed
it must remain permanent.
In cases of malfunction of a unit, it can be exchanged in
less than an hour. Consequently, any AU analyser which
contains more than one unit, can, to a certain degree,
supply its own back-up system. However, some parts of
the analyser have a common function, and, in the event of
failure, will cause the analyser to stop. The most
important of these is the sample rack transport system
and the data-processing unit.
TheAU configuration which was evaluated, anAU 5031,
consists of three units with eight reagent lines per unit. It
processes 150 samples per hour and with an additional
(optional) flame photometer carries out 26 tests per
sample. Twenty-four cuvettes are assigned to each test
and complete one cycle of the cuvette wheel in 8 min, and
24 s. If a test is not required for a given sample, the
cuvette passes empty and is washed. Consequently, the
processing speed remains constant regardless of the
number of tests required for a given sample.
Most of the reagents kits for the AU 5000 were from the
Merck Company in Darmstadt, FR Germany. However,
there are other suppliers who offer tests which are tailored
to this analyser. In addition, since this system is entirely
open, many commercial tests can be adapted to the
analyser.
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Table 1. Instrument specificationsfor the AU 5031.
1. Type of instrument
2. Test procedures
3. Specimen carrier
4. Sampling system
5 Sampling volumes
6 Sample dispensing
7 Urgent samples
8 Reagent storage
9 Reagent dispensor
10 Reagent volumes
11 Reaction rotor
12 Reaction cuvettes
13. Reaction time
14. Reaction temperature
15. Light source
16. Photometry system
17. Wavelength
18. Reaction solution
19. Sample cup
20. Test item selection
21. Data memory capacity
22. Quality control
23. Data processing
24. Water supply
25. Water consumption
26. Waste drainage
Discrete selective, automatic multianalyser.
End-point, endpoint with sample blank, kinetic with and without sample start, linear and non-
linear calibration, serum indices (haemolysis, lipaemia, hyperbilirubinaemia).
Straight racks with 10 positions for patient’s specimen (white), control sera (green), calibrators
(yellow), water and reagent blanks (blue) and emergency samples (Stats) (red). Specimen
identification via bar-code reader.
Pipettors in flame unit and each module with two liquid levei sensors driven by stepping motors.
3-15 btl in btl adjustable steps. Flame 50
Four tests -divided dispensing by means of micro syringe, constant volume pump.
Preferential processing of Stats possible.
Refrigerated storage (5-15 C). Ambient temperature storage compartment also provided.
Two independent pipettors per method.
Reagent and 2:50-500
Turntable with 192 cuvettes.
192 quartz glass cuvettes. 6 mm x 5 mm x 30 mm Pyrex glass cuvettes. Minimum volume 250
pathlength 6 mm.
8 min 24 s. 2nd reagent is dispensed after 3 min 36 s.
37 C +/- 0"2 C in a dry bath with incubation fluid circulation system.
Halogen lamp 12 V, 100 W.
Direct photometry in the reaction vessel. Measuring OD: 0"0-2"0. One or two wavelengths,
photodiode, 8-point photometry.
Interference filter: 340, 380, 410, 480, 520, 540, 570, 600, 660, 750 and 850 nm.
Through the rotating action of the stirring bar after the second reagent is dispensed.
16 x 100 mm, polystyrene tube.
Single, panels of tests or combined selection possible, definition of up to 10 panels.
Routine samples: 4000. Emergency samples 200.
Daily and day-to-day mean, range, standard deviation and coefficient of variation calculations and
graphs.
Correlation correction (AX + B), sample blank correction, data correction for each chemistry
(AX + B), serum quality judgement, abnormal upper/lower value judgement, calculation of test
ratios, work list, abnormal value/pending test list, test result editing for each sample.
Continuous flow, deionized with shut-off valve.
15 1/analyser unit/h.
Separately expelled: chemical and non-hazardous waste.
Methods
Agreement between photometer and temperature behaviour in
cuvettes
Two hardware conditions were investigated: the linearity
in all eight photometers in a unit and the temperature
behaviour in a cuvette after addition of cooled (8 C)
reagent 1.
For the linearity experiment, two solutions were prepared
with NADH and para-nitrophenol, respectively, which
covered in seven dilution steps the extinction range
between 0"5 and 3"0 for each solution. The extinctions of
each solution were measured in triplicate and were
plotted in eight parallel extinction curves for visual
inspection of linearity and parallelity.
The temperature in the cuvette was measured with a
micro temperature sensor in a cuvette to which 10 [al of
sample and, 12 s later, 500 btl of reagent was added. In
order to ensure that cooled reagent (8 C) reached the
cuvette, the reagent was dispensed repeatedly immedi-
ately before the experiment. The rationale of this
experiment was to check whether the temperature in the
cuvette reached 37 C before reading by photometer
1, 168 s later.
Table 2. Analyser configurations and throughput.
Number of units 2 3 4 6 8
Number of reagent lines per unit 12 12/8 8/4 8/4 4 4
Available tests per analyser 24 24/16 24/12 32/16 24 32
Sample processing capacity (per h) 50 100/150 150/300 150/380 300 300
Example: An Olympus analyser ofthe 5030 series consists ofthree units each ofwhich will be equipped with either eight or four reagent
lines. This will, for the total unit, yield 12 or 24 available tests, respectively, allowing a throughput of 150 or 300 samples/h,
respectively.Co Luley et al. Analytical performance of the Olympus AU 5031
Table 3. Reagents used during the evaluation.
Analyte Method Manufacturer
1. Enzymes
Alkaline
Alanine aminotransferase
’Opt. stand, method’J"
Opt. UV-test; modified
Amylase Substrate" 2-C1-PNP-
Aspartate aminotransferase
Creatine phosphokinase
y-glutamyl transferase (new)
Glutamate dehydrogenase
Lactate dehydrogenase
Lipase
Opt. UV-test; modified
’Opt. stand, method’
’Szasz’
’Opt. stand, method’
Opt. stand, method’
Turbidimetry substrate
Merck
14 000
Merck
IFCC method
14 344
Merck
3,D-maltoheptaosid
14 159/158
Merck
IFCC method
14 346
Merck
14 109/111
Merck
14056/057
Boehringer
124 320
Merck
3399
Boehringer
Triolein
262358
2. Flame photometry
Sodium
Potassium
With flame photometer
With flame photometer
Merck
Lithium as internal standard
Merck
Lithium as internal standard
3. Substrates
Blood urea nitrogen
Bilirubin
Calcium
Urease/glutamate dehydrogenase
2,5-Dichlorophenyl-diazonium salt
ortho-cresol-phthalein-complexon
Cholesterol Cholesterol oxidase/peroxidase
(CHOD-PAP)
Creatinine Modified Jaff without deproteiniza-
tion
Glucose Glucose dehydrogenase without
deproteinization
Phosphate Molybdate reaction
Iron Ferrozin method
Magnesium Xylidylblue
Total protein Biuret reaction
Triglycerides Enzymatic UV-test
Uric acid Uricase/peroxidase
Merck
14 135/137/161
Merck
14 162/163
Merck
19724
Merck
14 138/139/140/141
Mei-ck
19 726/727
Merck
14 051/055
Merck
19723
Merck
19725
Merck
19 736
Merck
3327
Merck
14 151/148
Merck
14 126/27/28
Optimized standard method according the Deutsche Gesellschaft f’tir Klinische Chemie.
NN: not yet in the catalogue.
Reagents and comparison instruments
The reagents used in this evaluation are listed in table 3.
The comparison instrument and the reagents used in the
comparison instrument are given in table 4. While some
comparison procedures were virtully identical (in par-
ticular most enzymes), the following were different in
either chemistry or test principle: amylase, BUN, biliru-
bin, calcium, magnesium and uric acid.. In addition,
there were differences in measurement temperatures:
while theAU 5031 works at 37 C some ofthe comparison
procedures operated at either 25C (amylase, lipase,
lactate dehydrogenase, BUN, cholesterol, creatinine,C. Luley et al. Analytical performance of the Olympus AU 5031
Table 4. Analytical instruments and tests usedfor method comparison.
Analyte Instrumen Method Reagents
1. Enzymes
Alkaline phosphatase
Alanine aminotransferase
Amylase
Aspartate aminotransferase
Creatine phosphokinase
y-glutamyl transferase (new)
Glutamate dehydrogenase
Lactate dehydrogenase
Lipase
2. Flame photometry
Sodium
Potassium
3. Substrates
Blood urea nitrogen
Bilirubin
Calcium
Cholesterol
Creatinine
Phosphate
Iron
Magnesium
Total protein
Triglycerides
ERIS
ERIS
COBAS BIO
ERIS
ERIS
ERIS
ERIS
COBAS BIO
HITACHI 7053
FL 74
FL 74
SMA
COBAS BIO6
FL 77
COBAS BIO
SMA
SMA
COBAS BIO6
FL7
COBAS BIO6
COBAS BIO6
Uric acid SMA
’Opt. stand, method’
Opt. UV-test; modified IFCC
method
Substrate: Maltotetraose
Opt. UV-test; modified IFCC
method
’Opt. stand, method’
Szasz’
’Opt. stand, method’
’Opt. stand, method’
UV-test; substrate: Triolein
With flame photometer
lithium as internal standard
With flame photometer
lithium as internal standard
Diacetyl monoxime method
Jendrassik Grof reaction
Atom absorption
Cholesterol oxidase/peroxidase
(CHOD-PAP)
Jaff6
Molybdate reaction
Ferrozin method
Atom absorption
Biuret
Enzymatic UV-test
Sodium tungstate method
Merck
19 711
Merck
19 709
G6decke
847 899
Merck
19 708
Merck
19 715
Merck
19 710
Merck
19 734
Merck
3399
Boehringer
262 358
Technicon
T40-0001
Hoffmann la
Roche
07 100 32
Boehringer
692 905
Technicon
T40-0004
Technicon
T40-0012
Hoffman la
Roche
07 105 98
Hoffman la
Roche
07 100 83
Merck
14 360
Technicon
T40-0014-00
ERIS: Eppendorf GerS.tebau Netheler + Hinz GmbH, Hamburg, FR Germany.
COBAS BIO: Hoffmann la Roche & Co. AG, Basel, Switzerland.
HITACHI: Boehringer, Mannheim, FR Germany.
FL 7: Zeiss GmbH, Oberkochem, FR Germany.
SMA: Technicon GmbH, Bad Vilbel, FR Germany.
COBAS BIO: Hoffmann la Roche & Co. AG, Basel, Switzerland.
FL 7: Zeiss GmbH, Oberkochem, FR Germany.C. Luley et al. Analytical performance of the Olympus AU 5031
phosphate, uric acid) or 30 C (bilirubin). All enzyme
activities which were measured on the AU 5031 at 37 C
were converted to corresponding activities at 25 C.
Imprecision
The within-run imprecision was determined from 20
measurements ofthree commercial control sera. Care was
taken to include a control serum containing normal
analyte levels (Monitrol I). The series were repeated
three times and the medians of the three CV values were
taken as the final results.
The same sera were used for the determination of
between-day imprecision, which was determined over 21
days (18 working days).
Predetermined factors were used for the measurement of
enzyme activities. Substrate and electrolyte concen-
trations were calibrated every day with the same
calibrator (’Calibrator for automated systems’,
Boehringer Mannheim GmbH, Catalogue No. 759 350).
The control sera used in this experiment are listed in table
5.
Carry-over
Carry-over effects are limited due to the construction
principle that each cuvette is used for one test only.
However, carry-over might occur as sample carry-over
due to insufficient cuvette washing (specimen-related
carry-over), through inadequate cleaning of the mixer
blades (specimen-independent carry-over).
Specimen-related carry-over
Sample carry-over was tested by determining the activity
of alkaline phosphatase during two complete cuvette
wheel cycles (N 48 samples). All samples were taken
from a serum pool with a low activity of 63 U/l, except
sample numbers 6 to 10 and 16 to 20 which contained the
very high activity of 5200 U/1. Thus, during the second
cuvette wheel cycle (sample numbers 25 to 48) samples
containing the low activity were measured in cuvettes
which were used for the determination of a very high
activity ofthe.analyte in the previous cuvette wheel cycle.
If the cuvettes are washed, residue of the sample with
high alkaline phosphatase activity should cause elevated
results in cuvette numbers 6 to 10 and 16 to 20,
respectively.
Drift effects were studied using three commercial and
control sera covering different levels of the analytes
measured. The sera were dissolved in the morning and
split into nine aliquots which were sealed and kept at 4C
until use. Measurements of aliquots were carried out
every 60 min for 8 h. For determination of alkaline
phosphase and bilirubin the sera were freshly reconsti-
tuted every 2 h.
Range limits
Linear ranges were investigated for all tests either by
diluting very high concentrations or activities, respec-
tively, ofthe analyte, or by spiking human serum with the
pure analyte. The measured concentrations were plotted
against dilutions and the resulting graphs were inspected
visually for linearity.
Specimen-independent carry-over
In order to investigate the potential reagent carry-over by
mixer blades, the combination of lipase and triglyceride
determinations was chosen. The first reagent line in a
single unit was used for lipase assay and the fifth reagent
line for the triglyceride test. Since samples were processed
in groups of four, the first of the four mixer blades stirred
first the lipase reaction mixture in cuvette and
subsequently (after the mixer blade washing procedure)
the reaction mixture for the triglyceride determination in
cuvette 5.
This should lead to falsely high measurements of
triglyceride if reaction solution was transferred from
cuvette (lipase assay) to cuvette 5 (triglyceride assay). If
the triglyceride determination only was required, the pre-
washed mixer blade just stirred the triglyceride reaction
solutions in cuvette numbers 5 + 8N (0 < N< 24) in this
unit. Thus, a potential carry-over from cuvettes + 8N to
Table 5. Control sera usedfor the AU 5031 evaluation
Serum in figures
Control serum Lot No. Manufacturer Control and 2
N + D Moni-trol I" 208 AHS/Deutschland GmbH, +
M + D Moni-trol II’ 108 Bereich Merz + Dade +
Validate N" 4 x 023 G6decke AG,
Validate A 4 x 625 Freiburg, FRG +
Seronorm 174 E. Merck AG,
Pathonorm L 20 Darmstadt, FRG
Pathonorm H 21
Precipath E 152147 Boehringer
Precipath U 151464 Mannheim GmbH,
Precinorm U 154290 FRG
Kontrollogen-L 623125 B Behringwerke
Kontrollogen-LP 623211 H AG, Marburg/Lahn
FRG
Used for determination of imprecision; all control sera were used in the recovery study.C. Luley et al. Analytical performance of the Olympus AU 5031
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Figure 1. Linearity and reproducibility ofall eightphotometers in a
unit as measured by dilutions ofparanitrophenol in triplicate (top).
The temperature course in a cuvette upon addition of precooled
(8 C) is displayed below.
cuvettes 5 + 8N could be investigated by measuring
triglycerides with and without determining lipase
activity. This was carried out by determining the
triglyceride levels in quadruplicate in 10 humanserum
samples, covering triglyceride levels between 0.4 and 4"3
mmol/1, with and without simultaneous lipase determi-
nations. The triglyceride values ofboth groups (with and
without lipase measurement) were compared by means of
the Wilcoxon test.
Assessment of accuracy
Recovery of assigned values in quality-control sera
Twelve commercial sera had been selected for the
determination of the recovery of assigned values in
control sera (see table 5).
Comparison with other analytical routine procedures
One hundred fresh human sera from daily routine
samples were determined in the AU 5031 analyser and in
the comparison instrument. Care was taken to ensure
simultaneous measurement of both instr,uments and to
include pathological analyte levels.
10%
Monitrol II
AP ALAT Amy. ASAT C,PK g_GT GIDH LDH LIp. Na" K
276 86 403 61 140 59 12 393 696 119 6.7
I0
Validate A
OR
AP ALAT Amy. ASAT OPK g_GT GIDH LDH LIp. Na K
248 54 248 60 148 61 17 313 303 124 7.5
U/I U/I U/I U/I U/I U/I U/I U/I U/I mmol/I mmol/I
within run between days betw. days. comp.
Figure 2(a). Imprecision (enzymes andflamephotometry): within-
run and between.days on both AU 5031 and the respective
comparison instruments. The assigned values in the three
commercial control sera are .given at the bottom of the graphs.C. Luley et al. Analytical performance of the Olympus AU 5031
Monitrol
5%
O%
BUN Bill C,a Chol C,rea In. P. Fe Mg Prot Trig Uric
5.21 22 2.26 4.6 112 0.6 28 0.96 67 0.95 306
Monitrol Ii
5%
O%
BUN Bill Ca Ghol Crea In.P. Fe Mg Prot Trig Uric
17 70 3.2 3.0 481 2.1 44 1.96 4.9 1.97 498
Results
Linearity of all eight photometers in a unit and temperature
behaviour in cuvettes
The extinction readings of a series of para-nitrophenol
dilutions were linear, parallel and reproducible for each
of the eight photometers (see figure 1, top). The time
% recoveryAanin
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-2 0 2 4 6 8
hours
----23 U/I --4--94 U/I 12 U/I
105%
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99%
97%
recovery Choestero
95%
-2 0 2
4.43 mmol/I
4 6 8
hours
--4-- 2.93 mmol/I + 5.26 mmol/I
Validate A
BUN Bill Ca Chol C,rea In,P, Fe Mg Prot Trig Uric
19 70 3.4 2.3 265 2.6 12 0.93 51 0.6 440
mmol/I umotll mmol/I mmol/I umolll rnmol/I umol/I mmol/I |/I mmol/I umol/I
I within run between days betw. days. comp.
Figure 2(b). Imprecison (substrates): within-run and between-
days on both AU 5031 and the respective comparison instruments.
The assigned values in the three commercial control sera are given at
the bottom of the graphs.
% recovery
o Caoiuffi
103%
lO1%
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2.2 mmol/I --F- 3.1 mmol/I + 2.3 mmol/I
Figure 3. Drift during 8 hfor three representative parameters. The
analyte activities and concentrations, respectively, are given at the
bottom of the graphs.C. Luley et al. Analytical performance of the Olympus AU 5031
Table 6. Assigned andfound values in three commercial control sera. Between-@ imprecision within-run imprecision. Three independent
series and median.
Analyte Control Assigned
(Units) material values
Imprecision
Within-run
Found Between
value days (Three series) Median
1. Enzymes
Alkaline phosphatase
(U/l)
Alanine aminotransferase
(U/l)
Amylase
(U/l)
Aspartate aminotransferase
(U/l)
Creatine phosphokinase
(U/l)
,-glutamyl transferase new
(U/l)
Glutamate dehydrogenase
(u/)
Lactate dehydrogenase
(U/l)
Lipase
(u/l)
2. Flame photometry
Sodium
(mmol/1)
Potassium
(mmol/1)
3. Substrates
Blood urea nitrogen
(mmol/1)
Bilirubin
(umol/1)
Calcium
(mmol/1)
Cholesterol
(mmol/1)
Creatinine
(umol/1)
Phosphate
(mmol/1)
Iron
(umol/1)
M-I 64 63 4"1 1"1 0"4 0’7 0"7
M-II 276 291 2"3 0"7 0"7 1"1 0"7
Val-A 248 237 2"0 0"6 0"5 0"5 0"5
M-I 23 17 3"7 0"6 0"7 0"7 0"7
M-II 86 64 1"7 0"9 1"0 1"9 1"0
Val-A 54 44 0"9 1"0 0"6 0"5 0"6
M-I 64 58 4"8 0"7 1"3 0"8 0"8
M-II 403 412 3"2 2"3 2"0 1"8 1"8
Val-A 248 275 1"3 0"8 5"3 0"7 0"8
M-I 26 21 3"3 0"0 0"6 0"8 0"6
M-II 61 52 2’0 1"9 1"4 1"4 1"4
Val-A 60 48 "9 1" 0"9 0"6 0"9
M-I 39 45 7"6 1’3 1"5 1.8 1"5
M-II 140 133 7"4 2"2 1.7 2"4 2"2
Val-A 148 136 3"9 2"6 0"8 2"4 2"4
M-I 14 12 6"5 1"3 1"5 1"6 1"5
M-II 59 51 4"4 1"5 2"5 0"0 1"5
Val-A 61 52 1"4 3"0 0"6 1"2 1"2
M-I 4"7 4 14"4 8"2 11"6 10"1 10"1
M-II 11"5 11 8"8 4"2 7"1 5"3 5"3
Val-A 17"3 16 5"2 4"0 8"3 4"0 4"0
M-I 181 167 4.1 0"4 1"5 0"4 0"4
M-II 393 358 3"2 1.0 0"6 0"3 0"6
Val-A 313 289 1" 7 0"5 0"5 0"5 0"6
M-I 388 396 5"0 1" 0"9 1"7 1.1
M-II 695 702 3"2 1"8 1"6 1"4 1.6
Val-A 303 317 2"2 0"9 0"9 0"8 0"9
M-I 139 140 2"3 0"4 0"0 1"0 0"4
M-II 119 117 2"0 0"0 0"0 0"2 0"0
Val-A 124 124 2"6 1"1 0"5 1"2 1"1
M-I 4"3 4"3 2"2 0"0 0"0 1"9 0"0
M-II 6"7 7"2 3"0 0"7 1"1 3"2 1"1
Val-A 7"5 6"9 3"5 0"9 0’ 7 2" 0"9
M-I 5"2 5 2"0 0"6 1"3 0"5 0"6
M-II 17"3 18 2"0 1"1 0"7 0"7 0"7
Val-A 18"9 17 4"6 0’4 0"4 0"5 0"4
M-I 22"1 22 6’4 1"3 0"7 2"4 1"3
M-II 70 84 3"2 2"9 0"0 4"6 2"9
Val-A 74 76 4"0 1"9 1"4 0"0 1"4
M-I 2"3 2"2 1"9 0"7 0"7 1"3 0"7
M-II 3"2 3"2 1"7 0"0 2"2 1"0 1"0
Val-A 3"4 3"0 2"2 1"6 0"9 0"7 0"9
M-I 4"6 4"4 2"0 0"4 0"7 0"7 0"7
M-II 3"0 2"8 2"0 0"6 0"5 0"5 0"5
Val-A 2"3 2"4 2"0 0"9 0"6 0"4 0’6
M-I 112 113 3"9 0"7 0"8 0"7 0"7
M-II 481 511 2"5 0"0 0"0 2"3 0"0
Val-A 265 307 2"4 1"3 1"2 0"0 1"2
M-I 0"9 0"8 3"8 ’2 0"8 0"9 0"9
M-II 2"1 1"9 2"8 2.0 1"6 1"8 1"’8
Val-A 2"6 2"4 2"5 0’8 0"9 0"9 0"9
M-I 29 28"0 2"4 1"2 1.2 1"8 1.2
M-II 44 42"0 3"5 1.8 1.6 1.1 1.6
Val-A 13 12"5 2"5 2"6 2"7 1"0 2’6C. Luley et al. Analytical performance of the Olympus AU 5031
Table 6-- continued.
Analyte Control Assigned
(Units) material values
Found
value
Imprecision
Within-run
Between
days (Three series) Median
Magnesium M-I 0"95
(mmol/1) M-II 1"96
Val-A 0"93
Total protein M-I 67
(mmol/1) M-II 48
Val-A 51
Triglycerides M-I 0-96
(mmol/1) M-II 1"97
Val-A 0"6
Uric acid M-I 305
(umol/1) M-II 498
1"0 4"9 0"8 5"1 1"4 1"4
1"6 4"4 1"6 3"6 1"0 1"6
1"8 3"7 0"9 2"6 0"9 0"9
64 3"5 1"0 1"2 0"8 1"0
44 3"2 0"7 0"0 1"1 0"7
44 3"4 0"0 0"5 0"9 0"5
0"9 2"8 1"0 0"6 1"6 1"0
2"1 2"6 1"4 1"0 1"7 1"4
0"8 3"3 1"0 1"1 0"9 1"0
299 1"9 0"7 0"5 0"9 0"7
534 2"2 0"8 1"1 0"4 0"8
Table 7. Linearity of the enzyme and substrate tests.
Unit
Upper limit of
Found linearity
Measured linear (declaration of
up to up to manufacturer)
Enzymes
Alkaline phosphatase U/1
Alanine aminot*ansferase U/l
Amylase U/1
Aspartate aminotransferase U/1
Creatine kinase U/1
y-glutamyltransferase U/1
Glutamate lact. dehydrogeanse U/1
Lactate dehydrogenase U/1
Lipase U/1
Substrates
Blood urea nitrogen mmol/1
Bilirubin [mol/l
Calcium mmol/1
Cholesterol mmol/l
Creatinine mol/1
Inorganic phosphate mmol/l
Iron tmol/1
Magnesium mmol/1
Total protein g/1
Triglycerides mmol/1
Uric acid tmol/1
5200 5200 1800
1930 1930 400
558 558 430
880 880 400
800 800 1100
2100 1790 1600
320 150 38
670 670 650
1200 650 700 (25 C)
44 44 33
430 430 390
6"5 6"5 5"1
17"2 17"2 15"5
2840 2840 2650
6"9 6"9 6"5
215 215 180
2"0 2"0 2"0
150 150 110
15"9 15"9 6"8
1770 1770 1190
course of temperature lowering caused by the addition of
cooled reagent showed that the reaction temperature of
37 C had been reached in the cuvette before reading by
photometer and additon of reagent 2 (168 and 204 s
later, respectively). This is illustrated in figure 1.
Imprecision
The within-run imprecision and the between-day impre-
cision are shown in figure 2(a) (enzymes) and figure 2(b)
(substrates). For two of the control sera the imprecision
values are also given for the comparison instruments. The
values presented in the figures are medians from three
independent measurement series. Exact figures are listed
in table 6.
It is apparent from this data that 15 of the 22 evaluated
tests gave a within-run imprecision ofbelow 1.5%. Six of
the seven remaining tests gave values below 2"9% -only
glutamate dehydrogenase gave a high imprecision which,
however, is not due to a failure of the test or of the
analyser, but is a consequence of the low activities which
are measured by this test. This performance can be rated
as very good.
The between-day imprecision was below 4.5% for at least
two out of three control sera. Exceptions were creatine
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Specimen carry-over
Alkaline phosphatase
U/I
66
64
62
6O
58
0
The samples below the bars were measured
in cuvettes in which an alkaline phos-
phatase activity of 5,200 U/I had been
determined a cuvette wheel cycle before.
2 4 6 8 10 12 14 16 18 20 22 24
Samples during a cuvette wheel cycle
Figure 4. Specimen-related carry.-over: alkaline phosphatase
measurements of 24 samples (one cycle of the cuvette wheel) of a
serum pool with low analyte activity. Samples with an activity of
alkaline phosphatase of5200 U/l had been measured in cuvettes 6
to 10 and 16 to 20, respectively, during the preceeding wheel cycle.
kinase (7"6, 7"2 and 2"9%) and, again, glutamate
dehydrogenase.
The between-day imprecisions of the comparison instru-
ment are also shown in figure 2 (for Monitrol I and II
only) the AU 5031 matches this performance.
Close imprecisions were reported by other evaluators
who found values surpassing the comparison instrument
[3].
Drift
The results of investigations on drift over 8 h were
inspected visually after blotting the percentage deviations
from the starting value (100%) over a time scale. Figure 3
displays three representative plots. A continuous trend
either increasing or decreasing could not be detected for
any of the 22 parameters. Deviations were below 5% for
all tests. This result is in contrast to Rohac et al. who
reported drifts for cholesterol, triglycerides and uric acid,
but did not discuss this finding further [3]. Hodgin et al.
omitted this aspect from their evaluation [2].
Linearities
Both the linearities found, and the linearity ranges
declared by the manufacturer, are given in table 7. The
linearities found were better than the manufacturer’s for
all tests with the exceptions of creatinine kinase and
lipase. In fact, a limited linearity was found only for
gamma-GT, glutamate dehydrogenase and lipase. For
the remaining tests the limitation of linearity is beyond
the highest value measured. The findings are in good
agreement with the results of other evaluators [2 and 3].
Specimen-related carry-over
A potential carry-over of sample residue due to an
insufficient washing of the cuvettes was investigated by
measuring alkaline phosphatase in cuvettes which had
been used before for the determination of the same
analyte in a very high activity (5200 U/l). The results
were compared with those which were obtained from the
same sample in cuvettes, which, a cuvette wheel before,
had been used for the determination of this analyte in a
low activity (62 U/l). The results are displayed in figure 4
which shows the measured values of this sample in 24
cuvettes (one cycle of the cuvette wheel). It is apparent
from the figure that no difference could be detected. The
Wilcoxon test did not show a significance difference
between both sets of values (p 0"84). Thus, the
specimen carry-over was smaller than 0"04%. Carry-over
effects between 0"1% and 5"33% were reported for
different parameters by other evaluators [1 and 2].
However, neither investigator took into consideration the
sequence of cuvettes which were assigned to the respect-
ive tests.
Specimen-independent carry-over
A carry-over caused by transfer of reagent due to an
insufficient washing of the mixer blades was tested in two
reagent lines which were served by the same mixer blade
(reagent line and reagent line 5). The triglycerides
values (means of quadruplicate measurement in reagent
line 5) in 10 serum samples did not differ in the Wilcoxon
test (p 0"76), regardless ofwhether concomitant lipase
determination had been carried out in reagent line 2 or
not. Rohac et al. carried out a similar experiment and
found a considerable carry-over leading to threefold
lipase measurements in combination with triglycerides.
Their results, however, are difficult to discuss because ofa
lack of experimental detail [3].
Assessment of accuracy
Recovery of assigned values in quality-control sera
The recovered values of all analytes in 10 commercial
control sera were expressed as percentage of the assigned
values. The medians and the 10th and 90th percentiles of
the respective values are displayed in figure 5. Fourteen of
22 tests yielded recoveries within the 5% range. Five tests
were in the range between 5% and 10% (y-glutamyl
transferase, lactate dehydrogenase, bilirubin, phosphate
and total protein) and three tests were in the range
between 10 and 18% (alanine aminotrans-ferase, aspar-
tate aminotransferase and creatinine).
Comparison with other analytical routine procedures
The results obtained by determination of all parameters
in 100 routine sera on the Olympus AU 5031 and on
routine instruments (see tables 3 and 4) were correlated
using the method ofBablock and Passing [4]. The results
of this statistical evaluation are given in table 8 and
figure 6.
The correlations were close for all tests. A correction was
unnecessary for eight out of22 tests (y-glutamyl transfer-
ase, sodium, blood urea nitrogen, cholesterol, creatinine,C. Luley et al. Analytical performance of the Olympus AU 5031
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Figure 5. Recove of assigned values in 12 commercial control sera. The columns represent medians and percentiles UOth, 90tN of the
percentage deviationsfrom the assigned values.
iron, triglycerides). The remaining 14 tests differed either
in slope (bilirubin, potassium), or in intercept (alanine
aminotransferase, creatinine phosphokinase, glutamate
dehydrogenase, lipase, inorganic phosphate, uric acid
and calcium), or both (alkaline phosphatase, amylase,
aspartate aminotransferase, magnesium and total pro-
tein). Statistical data are given in table 8, which displays
slope, intercept and the correlation coefficient after.
regression analysis according to the equation:y a * x +
b where y the AU 5031 and x the comparison
instrument. The reasons for the discrepancies were
various: different physiochemical methods on the com-
parison instruments (see tables 3 and 4), different
analysis temperatures (see the section on Reagents and
comparison instruments) and a lack ofaccuracy for some
methods on the AU 5031 (see figure 5). However, it is
unlikely that these discrepancies can be attributed to the
performance of the analyser but arise because of the
methodological discrepancies summarized above.
The results of these comparisons were discussed with the
manufacturers of the respective tests. In consequence,
factors of alkaline phosphatase and lactate dehydro-
genase have been corrected in accordance with data from
the laboratories evaluating the AU analyses.
Assessment ofpracticability
Despite the size and capacity of the analyser, the
Olympus AU 5031. is easy to run. It is easily accessible
from all sides and all mechanical movements can. be seen.
The data-processing software is sophisticated but can be
mastered by a technician after a training period of a few
days. The software contains an extensive diagnostic
program, which allows a specific detection of technical or
electronic problems. Together with a complete system of
LED controls of all mechanical movements problems can
rapidly be tracked to their origin thus allowing immediate
remedy or better communication with the Olympus
service.
The preanalytical preparation of the analyser consists of
four steps, which require the time periods given in
parentheses: warming up to 37 C (60 min); washing of
cuvettes and filling ofreagent lines with reagent (20 min);
reagent blanking plus running controls (20 min). In order
to circumvent the long warm-up phase the authors use an
electronic clock which starts the warming-up automati-
cally before routine work begins. Thus, the preanalytical
phase is reduced to 40 min and this time is required for
such routine activities as checking and replacing the
reagents.
During the evaluation period and the subsequent routine
work no total shut down of the analyser occurred.
However, during .the routine period a single unit broke
down twice: in both cases the reason was a faulty
adjustment of the sensors which control the movement of
the washing units. After correction in all three units this
problem did not occur again. The most practical and
most rapid solution for this emergency was toconcentrate
’vital’ tests on the remaining units. It was easier to
transfer reagents and programs from the faulty unit to the
other units, than to exchange the total unit as mentioned
above (’Description of the AU 5031 analyser’). This
transfer of tests was completed in less than 30 min,
including washing of the .reagent lines. The units were
repaired .by the Olympus service technicians before the
next morning. No other breakdown causing a severe
delay occurred thereafter.
Two modes of sample identification are possible: via
terminal or via bar-code identification. The manual
prescribes a correct positioning of the bar code onto the
sample cup; the vertical slant should be lower than 5
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Figure 6(a). Graphical plots of instrument comparison. Statistical data are listed in table 8.
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Figure 6(b). Graphical plots of instrument comparison. Statistical data are listed in table 8.
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However, angles up to 15 are read correctly. In addition,
the vertical position may vary up to 10 mm.
The following points would improve the performance of
the analyser.
(1) Changing from bar-code reading to sample identifi-
cation via the terminal required a complete termina-
tion of bar-code analyses. This causes inevitable
delays of 20 min for each change.
(2) The software which produces the print-out is inflex-
ible. For example, all available tests and references
ranges are printed, even if only one test has been
required for a given sample. In addition, flagging of
pathologic values (’high’ or ’low’) cannot be defined
differently for both sexes. As a result, this flag is set
only according to one reference range, either female
or male. Finally, the matrix printer which is delivered
NORCN PHOSPHATE 5MA AU 5031
with the analyser is slow and noisy. The authors have
connected a personal computer which runs a versa-
tile custom-made report software and serves a quiet,
and very rapid, ink-jet printer (the Epson SQ 2500).
(3) The tubing system by which the serum sample is
transported to the flame photometer consists of three
parts: two narrow tubes made of stainless steel and
silicone tubing. Frequent blocks in this system were
encountered, which were caused by tiny clots which
either pre-existed in the sample or resulted from
delayed clotting which could have been triggered by
contact with the materials described above. Since an
obstruction in the tubing system can result in time
losses ofup to 45 min this system should be replaced
by a continuous Teflon tubing.
These suggestions have been put to Olympus and it
appears that all three are being tested.
IRON: COBA5 AU 5031
MAGNESILId: FL AU 5031 TOTAL PROTEIN: COE]AS AU 5031
o
,;, g,
TRIGLYCERIDES: COBA5 AU 5031 URIC ACID: 5MA AU 5031
Figure 6(c). Graphical plots of instrument comparison. Statistical data are listed in table 8.
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Table 8. Comparison with routine instruments.
Method
Regression analysis (y a*x + b)
y AU 5031; x comparison instrument
SE standard error of the slope
CC correlation coefficient
N a SE b CC
1. Enzymes
Alkaline phosphatase 100
Alanine aminotransferase 100
Amylase 100
Aspartate aminotransferase 100
Creatin kinase 100
y-glutamyltransferase 100
Glutamate lact. dehydrogenase 100
Lactate dehydrogenase 100
Lipase 100
2. Flame photometry
Sodium 100
Potassium 100
3. Substrates
Blood urea nitrogen 100
Bilirubin 100
Calcium 100
Cholesterol 100
Creatinine 100
Inorganic phosphate 100
Iron 100
Magnesium 100
Total protein 100
Triglycerides 100
Uric acid 100
0"845 0"013 5"5 0’994
1"051 0"004 -2"6 0"999
3’925 0"005 -4"0 0"980
0’932 0"002 1"5 0’999
"000 0"005 8"0 0"999
"000 0"004 "0 0"999
1"012 0"008 1’2 0"998
0"972 0’010 -7"1 0"996
"062 0"011 6"6 0"982
1"002 0"032 0"7 0’948
0’993 0"017 0’ 0"986
’00 0’007 0"3 0"998
1’ 17 0"009 3"4 0"994
0"99 0"040 -0"1 0"942
0"98 0"019 0"0 0"985
0"97 0"0i3 18 0"994
1.00 0"023 -0’1 0"976
’00 0"013 0"8 0"984
0"97 0"012 0"2 0"989
1"24 0"024 -19 0"951
"02 0"007 0"0 0"998
0’97 0"017 -24 0"988
Conclusion
The Olympus AU 5031 is a powerful analyser which can
be tailored according to the needs of medium and large
laboratories. During the evaluation and the subsequent
routine period the analyser proved to be very reliable.
Both the photometer linearity in a unit and rapid
temperature equilibration upon addition of cooled re-
agent were found satisfactory. Imprecision values very
good, while the accuracy of some tests required correc-
tions. Correlations with other routine analysers was close.
Neither drift nor a carry-over were detected. Finally, due
to the wide ranges of most tests, only a few samples
needed to be re-run.
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